Patents by Inventor Reginald L. Hardy

Reginald L. Hardy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11179353
    Abstract: A composition comprising at least one TCA or SSRI useful in a method for preventing or treating a skin disorder such as radiation dermatitis, and method of preventing, ameliorating, or treating the skin disorder by administering an effective amount of the TCA, e.g., amitriptyline or the SSRI, e.g., sertraline.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: November 23, 2021
    Inventors: Reginald L. Hardy, Mitchell Brigell
  • Patent number: 11173111
    Abstract: A composition comprising at least one TCA useful in a method for treating an anorectal disorder, a rectal device and method of treating the anorectal disorder by anorectally administering an effective amount of the TCA, e.g. amitriptyline.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: November 16, 2021
    Assignee: Rythera Therapeutics, Inc.
    Inventors: Reginald L. Hardy, Mitchell Brigell